Valuation: Stereotaxis Inc

Market Cap 13Cr 11Cr 10Cr 9.33Cr 18Cr 1.2TCr 18Cr 119.73Cr 47Cr 596.58Cr 47Cr 46Cr 2TCr P/E 2026 *
-6.3x
P/E 2027 * -8.4x
Enterprise Value 13Cr 11Cr 10Cr 9.33Cr 18Cr 1.2TCr 18Cr 119.73Cr 47Cr 596.58Cr 47Cr 46Cr 2TCr EV / Sales 2026 *
3.19x
EV / Sales 2027 * 2.36x
Free-Float
84.7%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-2.84% - - 13Cr
-0.43%+1.06%+24.03%+3.71% 21TCr
-0.61%+1.82%-1.07%-24.39% 14TCr
+0.10%+4.69%-26.86%+12.57% 12TCr
+1.59%+5.60%-55.67%-7.68% 6.95TCr
-0.98%+4.16%+8.50%+7.08% 4.96TCr
+4.56%+7.82%-17.08%-20.95% 4.72TCr
-0.25%-0.14%+21.91%+8.35% 3.91TCr
-0.79%+0.70%+29.97%+29.32% 3.7TCr
+0.00%+5.67%+116.67%+8.20% 3.1TCr
Average -0.43%+3.19%+11.15%+1.80% 8.31TCr
Weighted average by Cap. +0.10%+2.80%+3.92%-0.66%

Financials

2026 *2027 *
Net sales 3.94Cr 3.43Cr 3.19Cr 2.93Cr 5.53Cr 376.11Cr 5.61Cr 38Cr 15Cr 187.25Cr 15Cr 14Cr 627.87Cr 5.33Cr 4.63Cr 4.31Cr 3.96Cr 7.47Cr 508.57Cr 7.59Cr 51Cr 20Cr 253.19Cr 20Cr 20Cr 848.97Cr
Net income -1.94Cr -1.69Cr -1.57Cr -1.44Cr -2.72Cr -185.19Cr -2.76Cr -19Cr -7.26Cr -92Cr -7.29Cr -7.13Cr -309.15Cr -1.36Cr -1.18Cr -1.1Cr -1.01Cr -1.91Cr -130.06Cr -1.94Cr -13Cr -5.1Cr -65Cr -5.12Cr -5Cr -217.12Cr
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-